Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Depreciation and Depletion (2020 - 2025)

Historic Depreciation and Depletion for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $100000.0.

  • NeuroPace's Depreciation and Depletion changed 0.0% to $100000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $256000.0, marking a year-over-year decrease of 1821.09%. This contributed to the annual value of $207000.0 for FY2024, which is 350.0% up from last year.
  • Latest data reveals that NeuroPace reported Depreciation and Depletion of $100000.0 as of Q3 2025, which was down 0.0% from $100000.0 recorded in Q2 2025.
  • NeuroPace's 5-year Depreciation and Depletion high stood at $100000.0 for Q1 2021, and its period low was $7000.0 during Q4 2024.
  • Moreover, its 5-year median value for Depreciation and Depletion was $100000.0 (2021), whereas its average is $83526.3.
  • In the last 5 years, NeuroPace's Depreciation and Depletion soared by 1690.14% in 2021 and then tumbled by 8970.59% in 2024.
  • NeuroPace's Depreciation and Depletion (Quarter) stood at $83000.0 in 2021, then grew by 4.82% to $87000.0 in 2022, then fell by 21.84% to $68000.0 in 2023, then plummeted by 89.71% to $7000.0 in 2024, then surged by 1328.57% to $100000.0 in 2025.
  • Its Depreciation and Depletion was $100000.0 in Q3 2025, compared to $100000.0 in Q2 2025 and $49000.0 in Q1 2025.